The peptide's effects on insulin sensitivity can be positive or negative depending on individual metabolic status
A 2000 study on female rats found that 12 weeks of this compound increased bone mineral content in the tibia and vertebrae, though this was linked to overall body weight gain, indicating its effects may be tied to general growth promotion (10)
Metabolism 69 , 148156 (2017)
Reviewed By Blake Gilliam, CRNP Reading Time: 4 minutes If you are using weight loss medications like GLP-1 receptor agonists and are considering intermittent fasting, you may wonder if combining the two will accelerate results or cause complications
However, the concept of microdosing extends beyond these realms and into hormone therapy, particularly with testosterone
The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice